ABVC BioPharma Inc.

0.74
-0.17 (-19.08%)
At close: Apr 04, 2025, 3:59 PM
0.82
11.05%
After-hours: Apr 04, 2025, 05:19 PM EDT

ABVC BioPharma Statistics

Share Statistics

ABVC BioPharma has 12.98M shares outstanding. The number of shares has increased by 7.66% in one year.

Shares Outstanding 12.98M
Shares Change (YoY) 7.66%
Shares Change (QoQ) 0%
Owned by Institutions (%) 1.78%
Shares Floating 11.24M
Failed to Deliver (FTD) Shares 3.22K
FTD / Avg. Volume 0.57%

Short Selling Information

The latest short interest is 186.19K, so 1.43% of the outstanding shares have been sold short.

Short Interest 186.19K
Short % of Shares Out 1.43%
Short % of Float 1.67%
Short Ratio (days to cover) 0.7

Valuation Ratios

The PE ratio is -0.48 and the forward PE ratio is -1.22. ABVC BioPharma's PEG ratio is 0.01.

PE Ratio -0.48
Forward PE -1.22
PS Ratio 32.99
Forward PS 0.3
PB Ratio 0.6
P/FCF Ratio -1.18
PEG Ratio 0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ABVC BioPharma.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.28, with a Debt / Equity ratio of 0.27.

Current Ratio 0.28
Quick Ratio 0.28
Debt / Equity 0.27
Debt / EBITDA -0.28
Debt / FCF -0.54
Interest Coverage -3.3

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $9.53K
Profits Per Employee $-657.23K
Employee Count 16
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax 256.01K
Effective Tax Rate -2.4%

Stock Price Statistics

The stock price has increased by -41.73% in the last 52 weeks. The beta is 0.33, so ABVC BioPharma's price volatility has been higher than the market average.

Beta 0.33
52-Week Price Change -41.73%
50-Day Moving Average 0.65
200-Day Moving Average 0.64
Relative Strength Index (RSI) 48.26
Average Volume (20 Days) 566.5K

Income Statement

In the last 12 months, ABVC BioPharma had revenue of 152.43K and earned -10.52M in profits. Earnings per share was -2.43.

Revenue 152.43K
Gross Profit -149.61K
Operating Income -8.22M
Net Income -10.52M
EBITDA -8.13M
EBIT -8.16M
Earnings Per Share (EPS) -2.43
Full Income Statement

Balance Sheet

The company has 60.16K in cash and 2.28M in debt, giving a net cash position of -2.22M.

Cash & Cash Equivalents 60.16K
Total Debt 2.28M
Net Cash -2.22M
Retained Earnings -65.42M
Total Assets 14.46M
Working Capital -4.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.24M and capital expenditures -21.2K, giving a free cash flow of -4.26M.

Operating Cash Flow -4.24M
Capital Expenditures -21.2K
Free Cash Flow -4.26M
FCF Per Share -0.98
Full Cash Flow Statement

Margins

Gross margin is -98.15%, with operating and profit margins of -5390.35% and -6898.68%.

Gross Margin -98.15%
Operating Margin -5390.35%
Pretax Margin -6989.62%
Profit Margin -6898.68%
EBITDA Margin -5335.18%
EBIT Margin -5390.35%
FCF Margin -2792.79%

Dividends & Yields

ABVC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ABVC.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Jul 25, 2023. It was a backward split with a ratio of 1:10.

Last Split Date Jul 25, 2023
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -7.5
Piotroski F-Score 3